Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|July 12, 2008
Histamine H2 receptor trafficking: role of arrestin, dynamin, and clathrin in histamine H2 receptor internalizationNatalia Fernandez, Federico Monczor, Alberto Baldi, et al.
Handbook of Experimental Pharmacology|June 19, 2016
Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid LeukemiaFederico Monczor, Sabrina Copsel, Natalia Fernandez, et al.
Biochemical Pharmacology|April 17, 2007
Regulatory mechanisms underlying GKR2 levels in U937 cells: evidence for GRK3 involvementNatalia Fernandez, Federico Monczor, Maria R Tubio, et al.
The Biochemical Journal|October 22, 2017
Synthesis and degradation of cAMP in Giardia lamblia: possible role and characterization of a nucleotidyl cyclase with a single cyclase homology domainVanina Saraullo, Nicolas Di Siervi, Belen Jerez, et al.
The Journal of Biological Chemistry|June 12, 2004
Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G proteinCarlos P Fitzsimons, Federico Monczor, Natalia Fernández, et al.
European Journal of Pharmacology|July 9, 2013
Antihistaminergics and inverse agonism: potential therapeutic applicationsFederico Monczor, Natalia Fernandez, Carlos P Fitzsimons, et al.
The Biochemical Journal|January 15, 2014
Signal transduction mechanism of biased ligands at histamine H2 receptorsNatalia Alonso, Federico Monczor, Emiliana Echeverría, et al.
Current Medicinal Chemistry|December 30, 2017
MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug DesignAgustín Yaneff, Ana Sahores, Natalia Gómez, et al.
Molecular Human Reproduction|May 2, 2017
Evidence for CB2 receptor involvement in LPS-induced reduction of cAMP intracellular levels in uterine explants from pregnant mice: pathophysiological implicationsAna Inés Salazar, Alejandro Carozzo, Fernando Correa, et al.
The Biochemical Journal|November 11, 2011
ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic miceLeda M Oliveri, Carlos Davio, Alcira M del C Batlle, et al.
Pageof 7